Literature DB >> 29569762

NDRG1 and FOXO1 regulate endothelial cell proliferation in infantile haemangioma.

Ji Won Byun1, Hye Young An1, Seung Dohn Yeom1, Seok Jong Lee2, Ho Yun Chung3.   

Abstract

The etiopathogenesis of infantile haemangioma has not been well understood, and it is accepted that angiogenic mediator dysregulation is the main contributor to the abnormal haemangioma capillary formation. The role of NDRG1, a hypoxia-inducible protein; FOXOs, which are tumor suppressor proteins; and the mTOR complex 2 pathway in infantile haemangioma have not been studied yet. The purpose of this study was to investigate NDRG1 and FOXO1 expression in the infantile haemangioma and the correlation of these proteins with proliferation and involution. Primary endothelial cells were obtained, with parental agreement, from 12 infantile haemangioma patients during surgery; 6 patients had proliferating infantile haemangiomas and 6 had involuting IHs. We compared the infantile haemangioma tissues and primary endothelial cells with human vein endothelial cells using microarrays, real-time PCR, Western blotting and immunohistochemical staining. Our data indicated that FOXO1 expression was downregulated in proliferating infantile haemangioma tissue. We found that the expression of NDRG1, a molecule upstream of the FOXO1 pathway, increased during haemangioma proliferation. NDRG1 knockdown decreased haemangioma endothelial cell proliferation and downregulated c-MYC oncoprotein levels. Our findings suggest that NDRG1 positively regulates haemangioma proliferation. FOXO1 dysregulation plays an important role in infantile haemangiomas pathogenesis.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FOXO1; NDRG1; infantile haemangioma

Mesh:

Substances:

Year:  2018        PMID: 29569762     DOI: 10.1111/exd.13541

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  6 in total

1.  Aberrant Neuregulin 1/ErbB Signaling in Charcot-Marie-Tooth Type 4D Disease.

Authors:  Li-Ting Jiang; Yu-Hui Chen; Jie-Hong Huang; Wei-Fang Tong; Ling-Jing Jin; Li-Xi Li
Journal:  Mol Cell Biol       Date:  2022-06-16       Impact factor: 5.069

2.  MiR-206 promotes extracellular matrix accumulation and relieves infantile hemangioma through targeted inhibition of DNMT3A.

Authors:  Minliang Wu; Yong Chen; Ling Feng; Haiying Dai; Shuo Fang; Jianguo Xu
Journal:  Cell Cycle       Date:  2021-05-04       Impact factor: 4.534

3.  The Influence of NDRG1 Single Nucleotide Polymorphisms on Glioma Risk and Prognosis in Chinese Han Population.

Authors:  Yonghui Yang; Yimin Cheng; Liting Yang; Guangyao Shi; Peng Chen; Liang Li; Hangrong Fang; Chao Chen; Tianbo Jin
Journal:  Cell Mol Neurobiol       Date:  2021-03-12       Impact factor: 5.046

4.  LINC00844 promotes proliferation and migration of hepatocellular carcinoma by regulating NDRG1 expression.

Authors:  Wei Zhou; Kang Huang; Qiuyan Zhang; Shaojun Ye; Zibiao Zhong; Cheng Zeng; Guizhu Peng; Ling Li; Qifa Ye
Journal:  PeerJ       Date:  2020-01-28       Impact factor: 2.984

5.  GEO Database Screening Combined with In Vitro Experiments to Study the Mechanism of hsa_circ_0003570 in Infantile Hemangiomas.

Authors:  Yu Tian; Shihao Zhuang; Jiantao Zhang; Tonghui You; Zihang Xu; Wanli Yang; Bin Hao; Weifeng Wang; Tao Yang
Journal:  Comput Math Methods Med       Date:  2022-04-28       Impact factor: 2.809

6.  Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration.

Authors:  Horacio Gomez-Acevedo; Yuemeng Dai; Graham Strub; Carrie Shawber; June K Wu; Gresham T Richter
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.